Key questions on genetic lipid disorders

Module summary

Specialists in cardiovascular disease and lipid management Professor Ahmet Fuat, Dr Jaimini Cegla, Dr Tina Khan and Dr Mayur Patel discuss key features of familial hypercholesterolaemia (FH) and other genetic lipid disorders, and how these should be diagnosed and managed in primary care.

Learning objectives

This module will enhance your understanding of genetic lipid disorders, including:

• The key features of FH and when to test for the condition.
• Different types of FH, their prevalence and associated risks.
• The process for screening and diagnosis of FH.
• How FH should be managed and the benefits of lipid-lowering interventions.
• Features of polygenic hypercholesterolaemia, its prevalence and associated risks.
• The contribution of Lipoprotein(a) to increased inherent CVD risk, when it should be tested for and how it is managed.

Authors: Professor Ahmet Fuat, GPSI in Cardiology in Darlington; Dr Jaimini Cegla, Consultant in Chemical Pathology and Metabolic Medicine, Imperial College Healthcare NHS Trust; Dr Tina Khan, Consultant Cardiologist, Royal Brompton and Harefield Hospitals; and Dr Mayur Patel, Consultant in Chemical Pathology and Metabolic Medicine, Oxford University Hospitals NHS Foundation Trust.

Date published: 12 December 2024